General Information
UEMS CME Accreditation 2026
We are pleased to inform you that all webinars 2026 have been granted 1 European CME credit (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).
Attendees need to attend the live webinar AND evaluate the webinar to receive the CME certificate.
The certificate of attendance/CME certificate will be sent approx. 1 week after the live webinar.
Recommended Bandwidth
The website www.speedtest.net offers you to check your bandwidth. We strongly recommend
• Upload min. 6Mbit required bandwidth (relevant for speakers, moderators sharing their camera and audio signal)
• Download min. 6Mbit required bandwidth
Also, we recommend a cable internet or a wireless connection with full signal.
Please note: Shared bandwidth (e.g. hospital, universities) will result in lower bandwidth for each user.
The webinars are open for
– all interested persons
– persons who have actively subscribed for the LCS certification (Step 1 of the programme outline)
Please note that webinar registrations are issued to an individual person and may neither be shared nor transferred to others under any circumstances. The use of automated systems, AI tools, or any form of proxy attendance in place of the actual attendee is strictly prohibited. Such actions are considered a violation of our participation policy and may lead to consequences, including revocation of the Certificate of Attendance, denial of CME credits and/or exclusion from future ESTI educational activities. We appreciate your understanding and cooperation in maintaining the integrity of our educational offerings.
Exclusive Sponsor 2026
- LCS Webinar 8.01
- LCS Webinar 8.02
- LCS Webinar 8.03
- LCS Webinar 8.04
- LCS Webinar 8.05
- LCS Webinar 8.06
- LCS Webinar 9.01
- LCS Webinar 9.02
- LCS Webinar 9.03
- LCS Webinar 9.04
- LCS Webinar 9.05
Monday, September 28, 18:00 CEST
Lung cancer screening trials: Current evidence and remaining questions
Speaker: Anna Rita Larici, Rome/IT | Moderator: Giuseppe Cicchetti, Rome/IT
General description, scope and objectives of this webinar
The programme of this webinar will cover a summary of results of lung cancer screening studies. It is aimed at thoracic/chest radiologists, radiologist residents/juniors, students and people who are interested in the ESTI LCS certification project who want to improve their skills in:
– Building a CT protocol for performing LCS at the recommended radiation dose level
– About the essential parts that influence a lung cancer program
– About the results of randomized and non-randomized trials thus far
After listening to the webinar, participants will:
– Compare the set ups of the various studies and their impact on results
– Appreciate new insights that have been gained after the publication of the two randomized trials, the NLST and the Nelson trial
– Judge which aspects are subjects of ongoing research in an attempt to further improve lung cancer screening
Monday, October 12, 18:00 CEST
Technical requirements for LCS: How to perform the acquisition, how to read the scans and the role of AI
Speaker: Constance De Margerie-Mellon, Paris/FR | Moderator: Thomas Frauenfelder, Zurich/CH
General description, scope and objectives of this webinar
This webinar will cover CT technical requirements and standardized reading criteria for LCS and will also underline the role of AI in chest CTs performed for LCS.
Meeting the technical requirements when performing chest CTs in the framework of LCS is important, to ensure a satisfying image quality while respecting the recommended radiation dose thresholds. Using appropriate and consistent reading criteria is also critical. As most detected nodules during screening are benign, such criteria allow adequate active management in case of suspicious nodule and imaging follow-up in indeterminate cases, while avoiding overdiagnosis. Finally, AI applications in LCS are booming and the number of AI-based commercial software is constantly growing. Strengths and weaknesses of AI for LCS will be discussed.
It is aimed at thoracic/chest radiologists, radiologist residents/juniors, students and people who are interested in the ESTI LCS certification project who want to improve their skills in:
– Building a CT protocol for performing LCS at the recommended radiation dose level
– Knowing about existing reading criteria for prevalent and incident lung nodules discovered on screening CTs
– Reviewing the potential role of AI for lung nodule detection, lung nodule classification, and for detection of associated comorbidities
After listening to the webinar, participants will:
– Apply the recommended technical requirement for performing chest CT in the LCS framework
– Indicate the adequate management for lung nodules detected during LCS
– Use AI tools for lung nodule detection while being aware of their limitations
Monday, November 16, 18:00 CET
Solid nodule morphological evaluation: How to recognize obviously benign/malignant nodules, how to recognize intrapulmonary lymph nodes, pitfalls
Speaker: Anand Devaraj, London/UK | Moderator: Jürgen Biederer, Heidelberg/DE
General description, scope and objectives of this webinar
The programme of this webinar will emphasise the importance of morphological assessment in lung nodule management. It is aimed at thoracic/chest radiologists, radiologist residents/juniors, students and people who are interested in the EST LCS certification project who want to improve their skills in:
– Management of incidental and screen detected nodules
After listening to the webinar, participants will:
– Understand the importance of morphology in distinguishing benign and malignant nodules
– Recognised typical features of intrapulmonary lymph nodes
– Appreciate the morphological appearances of atypical lung cancers
Monday, December 07, 18:00 CET
Solid nodule: Updates on follow-up and criteria of positive screens
Speaker: Mario Silva, Parma/IT | Moderator: Helmut Prosch, Vienna/AT
General description, scope and objectives of this webinar
The programme of this webinar will cover the management of screen detected solid pulmonary nodules. It is aimed at thoracic/chest radiologists, radiologist residents/juniors, students and people who are interested in the ESTI LCS certification project who want to improve their skills in:
– the risk prediction of solid pulmonary nodules
– the management of solid pulmonary nodules in lung cancer screening
After listening to the webinar, participants will:
– know how to classify solid pulmonary nodules
– understand the importance of a volumetric assessment of pulmonary nodules
– understand the rationale behind follow-up examinations
Monday, January 18, 18:00 CET
Subsolid nodules: Updates on evaluation, follow-up and criteria of positive screens
Speaker: Marie-Pierre Revel, Paris/FR | Moderator: Arjun Nair, London/UK
General description, scope and objectives of this webinar
The programme of this webinar will cover the topic of subsolid nodules. It is aimed at thoracic/chest radiologists, radiologist residents/juniors, who are interested in lung cancer screening who want to improve their skills in:
– The understanding of the pathological/radiological correlations
– The recognition of morphological features increasing the probability of invasive adenocarcinoma
After listening to the webinar, participants will:
– Distinguish between pure ground glass and part-solid nodules
– Report suspicious morphological signs
– Report relevant CT features such as significant growth
– Understand the concept of overdiagnosis
Monday, February 15, 18:00 CET
Incidental findings in lung cancer screening: What to report?
Speaker: Roberta Ledda, Parma/IT | Moderator: Mathias Prokop, Nijmegen/NL
General description, scope and objectives of this webinar
The programme of this webinar will cover the most important comorbidities and incidental findings in LDCT-based lung cancer screening. It is aimed at thoracic/chest radiologists, radiology residents/juniors, students and everybody who are interested in the ESTI LCS certification project and want to improve their skills in:
– The detection and categorization of comorbidities and incidental findings
– The reporting of comorbidities and incidental findings
– The definition and management of “actionable” incidental findings
After listening to the webinar, participants will:
– Have gained insight in the rationale of comorbidities and incidental findings detected on LDCT-based LCS
– Have learnt about the clinical significance of cardiovascular and respiratory diseases in the LCS population (“the Big 3 approach”)
– Have consolidated their knowledge about which incidental findings should be reported and which should not
– Be aware of the current recommendations and guidance on reporting and management of comorbidities and incidental findings in LCS
Monday, September 13, 18:00 CEST
Evidence Base for LCS. Trial evidence: NLST, NELSON, UKLS, LUSI, ITALUNG. EU Council 2022 Recommendation. Benefit-harm balance. Overdiagnosis. Cost-effectiveness
Speaker: Anna Rita Larici, Rome/IT | Moderator: Anagha P. Parkar, Bergen/NO
General description, scope and objectives of this webinar
This webinar will provide an evidence-based overview of contemporary lung cancer screening, summarizing the scientific evidence that supports low-dose CT (LDCT) screening and highlighting the major advances that have shaped current implementation studies and programmes. It is aimed at thoracic/chest radiologists, radiologist residents/juniors, students and people who are interested in the ESTI LCS certification project and who want to improve their skills in:
– Review the evidence supporting LDCT lung cancer screening, including the principal randomized and non-randomized trials and recent implementation studies
– Examine the current status of active LCS programmes in Europe
– Understand the requirements for implementing an effective and quality-assured lung cancer screening services
After listening to the webinar, participants will:
– Understand the scientific rationale and evidence supporting LDCT lung cancer screening
– Recognize the key innovations that improve screening performance
– Describe how current evidence and recommendations can support the implementation and optimization of high-quality, equitable lung cancer screening programmes across diverse healthcare systems
Monday, September 27, 18:00 CEST
Technical Standards for LDCT. CT acquisition protocols, dose optimisation, reconstruction. CAD and AI integration: Role, limitations, validation. QA metrics
Speaker: Constance De Margerie-Mellon, Paris/FR | Moderator: Roberta Ledda, Parma/IT
General description, scope and objectives of this webinar
This webinar will cover the technical requirements for CT acquisition in lung cancer screening (LCS), including radiation dose optimisation. It will also address the role of AI in chest CTs performed for LCS, as well as quality assurance (QA) metrics.
Meeting the technical requirements for chest CT in the framework of LCS is essential to ensure satisfactory image quality while respecting recommended radiation dose thresholds. Radiation protection is a key issue in the context of screening programmes involving repeated CT scans among participants who are, for the most part, disease-free. AI applications in LCS are expanding rapidly, and the number of AI-based commercial software solutions is constantly growing. The strengths and weaknesses of AI for LCS will be discussed.
This webinar is aimed at thoracic/chest radiologists, radiology residents/junior radiologists, students, and anyone interested in the ESTI LCS certification project who wishes to improve their skills in:
– Building a CT protocol for performing LCS at the recommended radiation dose level
– Reviewing the potential role of AI in lung nodule detection, lung nodule classification, and the detection of associated comorbidities
– Implementing QA metrics to monitor LCS programme quality
After listening to the webinar, participants will:
– Understand the challenges of radiation protection
– Apply the recommended technical requirements for performing chest CT within the LCS framework
– Use AI tools for lung nodule detection while being aware of their limitations
– Identify the key QA metrics used to monitor CT performance and dose consistency in an LCS programme
Monday, October 18, 18:00 CEST
Solid Nodule Evaluation. Morphological characterisation. Benign vs. malignant features. Intrapulmonary lymph nodes. Pitfalls and perceptual errors
Speaker: Chiara Pozzessere, Lausanne/CH | Moderator: Guillaume Chassagnon, Paris/FR
General description, scope and objectives of this webinar
The programme of this webinar will emphasise the importance of morphological assessment in the characterisation and management of solid nodules in lung cancer screening. It is aimed at thoracic/chest radiologists, radiologist residents/juniors, students and people who are interested in the ESTI LCS certification project who want to improve their skills in:
– Morphological assessment of solid pulmonary nodules
– Identification of key morphological features associated with benignity and malignancy
After listening to the webinar, participants will:
– Understand the importance of morphological assessment in the characterization and management of solid nodules in lung cancer screening beyond nodule size alone
– Recognise morphological features associated with benignity
– Identify morphological features suspicious of malignancy
– Apply a systematic approach to the morphological assessment of solid nodules
– Recognise common pitfalls and perceptual errors in the assessment of pulmonary nodules that may lead to false reassurance or overestimation of malignancy risk
Monday, November 22, 18:00 CET
Solid Nodule Measurement & Follow-up. Volumetry vs. diameter. Lung-RADS / ESTI positive screen criteria. Growth rate assessment. Inter-reader variability
Speaker: Anna Kerpel-Fronius, Budapest/HU | Moderator: Jürgen Biederer, Heidelberg/DE
General description, scope and objectives of this webinar
The programme of this webinar will cover solitary pulmonary nodule follow-up. It is aimed at thoracic/chest radiologists, radiologist residents/juniors, students and people who are interested in the ESTI LCS certification project who want to improve their skills in:
– The essentials of measuring solid pulmonary nodules
– Volumetric measurements and its role in growth rate assessment
– The basics of different nodule follow-up systems including LUNGRADS2.0 and the ESTI guidelines
After listening to the webinar, participants will:
– To measure and classify solid pulmonary nodules correctly
– Understand the principles of follow-up systems, and why they are needed in LCS
Monday, December 13, 18:00 CET
Subsolid Nodules. Part-solid and pure ground-glass classification. Follow-up intervals/ESTI Guidelines. Escalation criteria. Positive screen in subsolid nodules
Speaker: Gianluca Milanese, Parma/IT | Moderator: Annemiek Snoeckx, Edegem/BE
General description, scope and objectives of this webinar
The programme of this webinar will cover the topic of subsolid pulmonary nodules. It is aimed at thoracic/chest radiologists, radiologist residents/juniors, students and people who are interested in the ESTI LCS certification project who want to improve their skills in:
– Correctly identifying and classifying non-solid and part-solid nodules
– Recognising the morphological features relevant to risk stratification and management
– Applying the ESTI recommendations for follow-up and identifying criteria for management escalation
After listening to the webinar, participants will:
– Distinguish between non-solid and part-solid nodules and understand the clinical implications of this classification
– Apply the recommended follow-up intervals according to the ESTI guidelines
– Identify imaging findings that warrant escalation of management and recognise when a subsolid nodule should be considered a positive screening result
